fluconazole has been researched along with Disbacteriosis in 4 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheng, B | 1 |
| Chen, Y | 1 |
| Sun, L | 1 |
| Xu, P | 1 |
| Han, B | 1 |
| Li, X | 1 |
| Yin, J | 1 |
| Li, T | 1 |
| Guan, H | 1 |
| Chen, S | 1 |
| Wang, Q | 1 |
| Li, C | 1 |
| Li, S | 1 |
| Jiang, X | 1 |
| Wang, P | 1 |
| He, Q | 1 |
| Wang, Y | 1 |
| Xiao, W | 1 |
| Yang, H | 1 |
| Donders, GG | 1 |
| Grinceviciene, S | 1 |
| Ruban, K | 1 |
| Bellen, G | 1 |
| Hiengrach, P | 1 |
| Panpetch, W | 1 |
| Worasilchai, N | 1 |
| Chindamporn, A | 1 |
| Tumwasorn, S | 1 |
| Jaroonwitchawan, T | 1 |
| Wilantho, A | 1 |
| Chatthanathon, P | 1 |
| Somboonna, N | 1 |
| Leelahavanichkul, A | 1 |
| Wheeler, ML | 1 |
| Limon, JJ | 1 |
| Bar, AS | 1 |
| Leal, CA | 1 |
| Gargus, M | 1 |
| Tang, J | 1 |
| Brown, J | 1 |
| Funari, VA | 1 |
| Wang, HL | 1 |
| Crother, TR | 1 |
| Arditi, M | 1 |
| Underhill, DM | 1 |
| Iliev, ID | 1 |
4 other studies available for fluconazole and Disbacteriosis
| Article | Year |
|---|---|
Antifungal Treatment Aggravates Sepsis through the Elimination of Intestinal Fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dysbiosis; Feces; Fluconazole; F | 2021 |
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Bacteria; Candida; Candidiasis, Vulvovaginal; D | 2020 |
Administration of Candida Albicans to Dextran Sulfate Solution Treated Mice Causes Intestinal Dysbiosis, Emergence and Dissemination of Intestinal Pseudomonas Aeruginosa and Lethal Sepsis.
Topics: Animals; Candida albicans; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Fluconazole; Gastroin | 2020 |
Immunological Consequences of Intestinal Fungal Dysbiosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Bacteria; Base Sequence; Colitis; Dietary Supplements; D | 2016 |